Mark Hull Selected Research

Mark Hull Research Topics

Disease

12	Coinfection 01/2023 - 01/2013
11	COVID-19 12/2023 - 10/2021
10	Infections 10/2023 - 01/2013
8	Hepatitis C 01/2019 - 07/2014
4	HIV Infections (HIV Infection) 02/2022 - 01/2016
4	Fibrosis (Cirrhosis) 01/2021 - 01/2015
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 01/2016
4	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 12/2014
3	Reinfection 10/2023 - 01/2015
3	Chronic Renal Insufficiency 01/2018 - 01/2016
3	End Stage Liver Disease 01/2017 - 01/2016
2	Syphilis 05/2024 - 01/2020
2	Viremia 01/2023 - 01/2022
2	Substance-Related Disorders (Drug Abuse) 12/2021 - 05/2015
2	Obesity 01/2020 - 10/2016
2	Chronic Hepatitis B 01/2017 - 01/2016
2	Liver Diseases (Liver Disease) 11/2014 - 01/2013
1	Gonorrhea 01/2022
1	Binge Drinking 01/2021
1	Diabetes Mellitus 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Rectal Neoplasms (Rectal Cancer) 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Hepatitis 11/2016
1	Crohn Disease (Crohn's Disease) 10/2016
1	Necrosis 10/2016
1	Lung Neoplasms (Lung Cancer) 02/2013

Drug/Important Bio-Agent (IBA)

12	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2013
7	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2013
6	VaccinesIBA 12/2023 - 10/2021
6	InterferonsIBA 01/2023 - 07/2014
3	Ribavirin (Virazole)FDA LinkGeneric 01/2021 - 07/2014
3	SimeprevirIBA 04/2016 - 11/2014
3	SofosbuvirIBA 04/2016 - 11/2014
2	Doxycycline (Periostat)FDA LinkGeneric 05/2024 - 01/2020
2	trans-crotonin (CTN)IBA 10/2023 - 12/2021
2	N-(2-cyanoethylene)urea (BA 1)IBA 10/2023 - 01/2023
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2021
2	Tenofovir (Viread)FDA Link 01/2023 - 01/2016
2	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2022 - 12/2021
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2016
2	Interferon LambdaIBA 01/2017 - 03/2015
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2016 - 11/2014
1	Messenger RNA (mRNA)IBA 10/2023
1	Proteins (Proteins, Gene)FDA Link 10/2023
1	entecavir FDA Link 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	Cocaine (Cocaine HCl)IBA 01/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	C-Reactive ProteinIBA 01/2017
1	Lipopolysaccharide ReceptorsIBA 01/2017
1	Chemokine CCL5IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Infliximab (Remicade)FDA Link 10/2016
1	AntibodiesIBA 10/2016
1	sofosbuvir drug combination ledipasvirIBA 04/2016
1	Ritonavir (Norvir)FDA Link 04/2016
1	dasabuvirIBA 04/2016
1	ombitasvirIBA 04/2016
1	paritaprevirIBA 04/2016
1	daclatasvirIBA 04/2016
1	Emtricitabine (Emtriva)FDA Link 01/2016
1	lamivudine drug combination abacavir FDA Link 01/2016
1	RacivirIBA 01/2016
1	Reverse Transcriptase InhibitorsIBA 01/2016
1	Aspartic Acid (Aspartate)FDA Link 01/2016
1	TransferasesIBA 01/2016
1	Citalopram FDA LinkGeneric 07/2014
1	SmokeIBA 02/2013

Therapy/Procedure

18	Therapeutics 12/2023 - 01/2013
4	Highly Active Antiretroviral Therapy (HAART) 01/2018 - 01/2016
2	Art Therapy 01/2023 - 12/2014
1	Retreatment 10/2023
1	Condoms (Condom) 01/2022
1	Continuity of Patient Care 01/2022
1	Bariatric Surgery 01/2020
1	Secondary Prevention 11/2016
1	Liver Transplantation 01/2016
1	Aftercare (After-Treatment) 05/2015